FDA Inspection 1164808 — Pasi A. Janne, M.D., Ph.D.
The FDA completed an inspection of Pasi A. Janne, M.D., Ph.D. on February 16, 2022 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 16, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Boston, MA (United States)
Additional Details
Clinical Investigator (CI)